Contact

Serving men and women for over 30 years, we are the triad’s premier center for advanced hair removal procedures and specialty skin rejuvenation.

High Point Office

336.841.4025

3750 Admiral Drive, Suite 106

Mon & Fri 9-5

Tues, Wed and Thurs 9-7:30 | Sat 9-4

Greensboro Office

336.288.5660

2105-B W Cornwallis Drive

Mon 9-7:30 | Tues & Thurs 9-7:00

Wed 9-6 | Fri 9-5 | Sat 9-4

[contact-form-7 id="5" html_class="cf7_custom_style_1"]
 

Xeomin®

Xeomin® is a smart toxin with a double-filtered formula that removes unnecessary proteins, so you get only what’s needed for smoother frown lines, treatment after treatment.

The Smart Toxin Formula

We believe the purity and performance of the product matter. That’s why we take the time to double filter our smart toxin with a proprietary XTRACT Technology™ process.

Treatment After Treatment*

Our unique formula removes unnecessary proteins so the active ingredient contains only what is needed to smooth frown lines, treatment after treatment.* Time is on your side, and so are we.

A LIFE WELL-LOVED DESERVES
A FORMULA THAT’S WELL-MADE.

FDA APPROVED. CLINICALLY PROVEN.

Frown lines form when facial expressions are made as the muscle under the skin contracts. Over time, as your skin ages, these repeated expressions cause lasting frown lines. Neurotoxins, such as Xeomin®, are prescription medications that block the release of chemicals that cause these muscle contractions so frown lines are softened.

STATE-OF-THE-ART MANUFACTURING PROCESS.

Xeomin® is made through a unique precision manufacturing process called XTRACT Technology™, that uses two filtration steps to isolate the therapeutic component of the molecule and removes the complexing/unnecessary proteins that don’t play an active role in treatment. Xeomin® is a double-filtered neurotoxin. Head-to-head studies evaluating the relative risk of immunogenicity due to the presence or absence of complexing/unnecessary proteins have not been performed.

*In clinical studies, no patients demonstrated a secondary lack of treatment response due to neutralizing antibodies. Head-to-head studies evaluating the relative risk of immunogenicity due to the presence or absence of complexing/unnecessary proteins have not been performed.

Schedule Your Consultation

Call us today for a free, private consultation.

High Point: 336.841.4025
Greensboro: 336.288.5660